請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37581完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 江俊斌(Chun-Pin Chiang) | |
| dc.contributor.author | Wei-Chuan Chen | en |
| dc.contributor.author | 陳韋全 | zh_TW |
| dc.date.accessioned | 2021-06-13T15:33:37Z | - |
| dc.date.available | 2008-08-08 | |
| dc.date.copyright | 2008-08-08 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-14 | |
| dc.identifier.citation | Aggelopoulou EP, Skarlos D, Papadimitriou C, Kittas C , Troungos C. Human papilloma virus DNA detection in oral lesions in the Greek population. Anticancer Res 1999; 19: 1391-5.
Alani RM , Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998; 16: 330-7. Antinore MJ, Birrer MJ, Patel D, Nader L , McCance DJ. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J 1996; 15: 1950-60. Autillo-Touati A, Joannes M, d'Ercole C, Robaglia-Schlupp A, Lambert A, Mazzella E, Blanc B , Seite R. HPV typing by in situ hybridization on cervical cytologic smears with ASCUS. Acta Cytol 1998; 42: 631-8. Axell T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontologisk Revy Supplement 1976; 36: 1-103. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20 333 adult Swedish people. Community Dent Oral Epidemiol 1987; 15: 46-51. Axell T, Pindborg JJ, Smith CJ , van der Waal I. Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996; 25: 49-54. Baez A, Almodovar JI, Cantor A, Celestin F, Cruz-Cruz L, Fonseca S, Trinidad-Pinedo J , Vega W. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 2004; 26: 778-84. Bagan JV, Jimenez Y, Murillo J, Gavalda C, Poveda R, Scully C, Alberola TM, Torres-Puente M, Perez-Alonso M, Bagan JV, Jimenez Y, Murillo J, Gavalda C, Poveda R, Scully C, Alberola TM, Torres-Puente M , Perez-Alonso M. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg 2007; 65: 46-9. Bagan JV, Murillo J, Poveda R, Gavalda C, Jimenez Y, Scully C, Bagan JV, Murillo J, Poveda R, Gavalda C, Jimenez Y , Scully C. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs. Oral Oncol 2004; 40: 440-3. Batsakis JG, Suarez P , el-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol 1999; 35: 354-9. Bauer H, Greer C , Manos M. Determination of genital human papillomavirus infection by consensus PCR amplification. In: HERRINGTON C , MCGEE J eds. Diagnostic molecular pathology: a practical approach. IRL Press at Oxford University Press: Oxford, 1992; 131-152. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A , Fraumeni JF, Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R , Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.[see comment]. J Natl Cancer Inst 1995; 87: 796-802. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS , Kittas C. 'High risk' HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-53. Bouquot JE , Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 1986; 61: 373-81. Bouquot JE , Gundlach KK. Odd lips: the prevalence of common lip lesions in 23,616 white Americans over 35 years of age. Quintessence Int 1987; 18: 277-84. Bouquot JE , Whitaker SB. Oral leukoplakia--rationale for diagnosis and prognosis of its clinical subtypes or 'phases'. Quintessence Int 1994; 25: 133-40. Braakhuis BJM, Snijders PJF, Keune WJH, Meijer C, Ruijter-Schippers HJ, Leemans CR , Brakenhoff RH. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004; 96: 998-1006. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ , Kouzarides T. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 1999; 18: 2449-58. Brugere J, Guenel P, Leclerc A , Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986; 57: 391-5. Cabay RJ, Morton TH, Jr. , Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med 2007; 36: 255-61. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W , Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92. Campisi G, Di Fede O, Giovannelli L, Capra G, Greco I, Calvino F, Maria Florena A , Lo Muzio L. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. Oral Oncol 2005a; 41: 994-1004. Campisi G, Giovannelli L , Ammatuna P. Human papillomavirus frequency in oral epithelial lesions.[comment]. J Oral Pathol Med 2005b; 34: 62-3; author reply 63-4. Campisi G, Giovannelli L, Ammatuna P, Capra G, Colella G, Di Liberto C, Gandolfo S, Pentenero M, Carrozzo M, Serpico R , D'Angelo M. Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection. Oral Oncol 2004a; 40: 835-40. Campisi G, Giovannelli L, Arico P, Lama A, Di Liberto C, Ammatuna P , D'Angelo M. HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, And Endodontics 2004b; 98: 705-11. Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S, Di Liberto C, Scully C , Lo Muzio L. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol 2007; 30: 813-23. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME , Lorincz A. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002; 11: 1394-9. Castro TPPG , Bussoloti Filho I. [Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx]. Revista Brasileira de Otorrinolaringologia 2006; 72: 272-82. Chang JYF, Lin MC , Chiang CP. High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol 2003; 120: 909-16. Chang KC, Su IJ, Tsai ST, Shieh DB , Jin YT. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology 2002; 63: 362-9. Chen GS , Chen CH. A Statistical Analysis of Oral Squamous Cell Carcinoma (Chinese). Kaohsiung J Med Sci 1995; 11: 582-588. Chen PCH, Kuo C, Pan CC , Chou MY. Risk of oral cancer associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan--an integrated molecular and epidemiological study of 58 cases. J Oral Pathol Med 2002; 31: 317-22. Chen PCH, Pan CC, Kuo C , Lin CP. Risk of oral nonmalignant lesions associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: an integrated molecular and epidemiologic study. Arch Pathol Lab Med 2006; 130: 57-61. Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ , Kuo MY. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 72-6. Chiang CP, Lang MJ, Liu BY, Wang JT, Leu JS, Hahn LJ , Kuo MY. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia. J Formos Med Assoc 2000; 99: 229-34. Cho NH, An HJ, Jeong JK, Kang S, Kim JW, Kim YT , Park TK. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol 2003; 188: 56-62. Chung CH, Yang YH, Wang TY, Shieh TY , Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med 2005; 34: 460-6. Cianfriglia F, Di Gregorio DA, Cianfriglia C, Marandino F, Donnorso RP , Vocaturo A. Incidence of human papillomavirus infection in oral leukoplakia. Indications for a viral aetiology. J Exp Clin Cancer Res 2006; 25: 21-28. Clavel C, Masure M, Putaud I, Thomas K, Bory JP, Gabriel R, Quereux C , Birembaut P. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 1998; 51: 737-40. Cox JT. Epidemiology and natural history of HPV. J Fam Pract 2006; Suppl: 3-9. Cox M, Maitland N , Scully C. Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa. Eur J Cancer 1993; Part B, Oral Oncology. 29B: 215-9. D'Costa J, Saranath D, Dedhia P, Sanghvi V , Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998; 34: 413-20. Demers GW, Foster SA, Halbert CL , Galloway DA. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci U S A 1994; 91: 4382-6. Duggan MA, Inoue M, McGregor SE, Stuart GC, Morris S, Chang-Poon V, Schepansky A , Honore L. A paired comparison of dot blot hybridization and PCR amplification for HPV testing of cervical scrapes interpreted as CIN 1. Eur J Gynaecol Oncol 1994; 15: 178-87. Dunne EF, Nielson CM, Stone KM, Markowitz LE , Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194: 1044-57. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS , Markowitz LE. Prevalence of HPV infection among females in the United States.[see comment]. JAMA 2007; 297: 813-9. Dupuy C, Buzoni-Gatel D, Touze A, Le Cann P, Bout D , Coursaget P. Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb Pathog 1997; 22: 219-25. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE , Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987; 1: 251-6. Dyson N, Howley PM, Munger K , Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-7. Elamin F, Steingrimsdottir H, Wanakulasuriya S, Johnson N , Tavassoli M. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection. Oral Oncol 1998; 34: 191-7. Fahey MT, Irwig L , Macaskill P. Meta-analysis of Pap test accuracy.[see comment]. Am J Epidemiol 1995; 141: 680-9. Fehrmann F , Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003; 22: 5201-7. Femiano F, Gombos F , Scully C. Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL. Int J Oral Maxillofac Surg 2001; 30: 318-22. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu P, Russo PA , Yotov WV. Direct human papillomavirus (HPV) sequencing method yields a novel HPV in a human immunodeficiency virus-positive Quebec woman and distinguishes a new HPV clade. J Infect Dis 1998a; 178: 1492-6. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu P, Simard P, Russo PA , Yotov WV. A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diagn Mol Pathol 1998b; 7: 317-23. Feoli-Fonseca JC, Oligny LL, Filion M, Simard P, Russo PA , Yotov WV. JC9813-A putative novel human papillomavirus identified by PCR-DS. Biochem Biophys Res Commun 1998c; 250: 63-7. Forslund O, Antonsson A, Nordin P, Stenquist B , Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80: 2437-43. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK, Stisser K, Konig R , Tyring SK. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 2004; 122: 87-93. Gonzalez JV, Gutierrez RA, Keszler A, Colacino MDC, Alonio LV, Teyssie AR , Picconi MA. Human papillomavirus in oral lesions. Medicina-Buenos Aires 2007; 67: 363-368. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR , Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-61. Gravitt PE, Peyton CL, Apple RJ , Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36: 3020-7. Greer RO. Pathology of malignant and premalignant oral epithelial lesions. Otolaryngol Clin North Am 2006; 39: 249-75. Greer RO, Jr. , Poulson TC. Oral tissue alterations associated with the use of smokeless tobacco by teen-agers. Part I. Clinical findings. Oral Surg Oral Med Oral Pathol 1983; 56: 275-84. Gregoire L, Arella M, Campione-Piccardo J , Lancaster WD. Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol 1989; 27: 2660-5. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D , Califano JA. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002; 8: 1203-9. Halbert CL, Demers GW , Galloway DA. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 1991; 65: 473-8. Hansen LS, Olson JA , Silverman S, Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 1985; 60: 285-98. Hashibe M, Jacob BJ, Thomas G, Ramadas K, Mathew B, Sankaranarayanan R , Zhang ZF. Socioeconomic status, lifestyle factors and oral premalignant lesions. Oral Oncol 2003; 39: 664-71. Havre PA, Yuan J, Hedrick L, Cho KR , Glazer PM. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 1995; 55: 4420-4. Haya-Fernandez MC, Bagan JV, Murillo-Cortes J, Poveda-Roda R , Calabuig C. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis 2004; 10: 346-8. Hesselink AT, van den Brule AJ, Groothuismink ZM, Molano M, Berkhof J, Meijer CJ, Snijders PJ, van den Brule AJC, Groothuismink ZMA, Meijer CJLM , Snijders PJF. Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens. J Clin Microbiol 2005; 43: 4868-71. Hesselink AT, van den Brule AJC, Brink AATP, Berkhof J, van Kemenade FJ, Verheijen RHM , Snijders PJF. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 2004; 102: 11-8. Hinds P, Finlay C , Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989; 63: 739-46. Hogewind WF , van der Waal I. Prevalence study of oral leukoplakia in a selected population of 1000 patients from The Netherlands. Community Dent Oral Epidemiol 1988; 16: 302-5. Holmstrup P, Vedtofte P, Reibel J , Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006; 42: 461-74. Hopman AHN, Smedts F, Dignef W, Ummelen M, Sonke G, Mravunac M, Vooijs GP, Speel EJM , Ramaekers FCS. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004; 202: 23-33. Horn PL, Lowell DM, LiVolsi VA , Boyle CA. Reproducibility of the cytologic diagnosis of human papillomavirus infection. Acta Cytol 1985; 29: 692-4. Huang CC, Qiu JT, Kashima ML, Kurman RJ , Wu TC. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method.[see comment]. Mod Pathol 1998; 11: 971-7. Huang HJ, Huang SL, Lin CY, Lin RW, Chao FY, Chen MY, Chang TC, Hsueh S, Hsu KH , Lai CH. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 2004; 14: 639-49. Jaber MA, Porter SR, Speight P, Eveson JW , Scully C. Oral epithelial dysplasia: clinical characteristics of western European residents. Oral Oncol 2003; 39: 589-96. Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang ZF, Sankaranarayanan R, Hashibe M, Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang Z-F, Sankaranarayanan R , Hashibe M. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol 2004; 40: 697-704. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ , Walboomers JM. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-5. Jones DL, Alani RM , Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 1997; 11: 2101-11. Josefsson A, Livak K , Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5' exonuclease assay. J Clin Microbiol 1999; 37: 490-6. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO , Gyllensten UB. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.[see comment]. Lancet 2000; 355: 2189-93. Kerstens HM, Poddighe PJ , Hanselaar AG. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 1995; 43: 347-52. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P , von Knebel Doeberitz M. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59: 6132-6. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M , Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-17. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B , Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.[see comment]. Am J Pathol 1998; 153: 1731-9. Kramer IR, Lucas RB, Pindborg JJ , Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518-39. Kulasegaram R, Downer MC, Jullien JA, Zakrzewska JM , Speight PM. Case-control study of oral dysplasia and risk habits among patients of a dental hospital. European Journal of Cancer Part B, Oral Oncology 1995; 31B: 227-31. Kurose K, Terai M, Soedarsono N, Rabello D, Nakajima Y, Burk RD , Takagi M. Low prevalence of HPV infection and its natural history in normal oral mucosa among volunteers on Miyako Island, Japan. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2004; 98: 91-96. Lee FH, Yen CY , Liu SY. Proliferative Verrucous Leukoplakia -A Preliminary Study. Chinese Journal of Oral and Maxillofacial Surgery 1998; 9: 47-58. Lee JJ, Kok SH, Kuo YS, Yang PJ , Hahn LJ. Carcinoma of the Buccal Mucosa: A Representative Betel Nut Oral Cancer. Formosan Journal of Medicine 1997; 1: 638-647. Lin HP. The expression of p53, MDM-2, p21, heat shock and HPV 16/18 E6 proteins in oral verrucous carcinoma and verrucous hyperplasia. Master Thesis, Natioanl Taiwan University, 1997. Lin YS , Leu YS. Proliferative Verrucous Leukoplakia: Case Report. Taiwan Journal of Family Medicine 2005; 15: 108-117. Longworth MS , Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004; 68: 362-72. Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I , zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 1985; 84: 417-20. Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996; 23: 707-30. Lungu O, Wright TC, Jr. , Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 1992; 6: 145-52. Luo CW, Roan CH , Liu CJ. Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. Int J Oral Maxillofac Surg 2007; 36: 153-8. Magal SS, Jackman A, Pei XF, Schlegel R , Sherman L. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int J Cancer 1998; 75: 96-104. Mashberg A, Boffetta P, Winkelman R , Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993; 72: 1369-75. Massimi P, Pim D , Banks L. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. J Gen Virol 1997; 78: 2607-13. Mayne ST , Morse DE. Nutrition and Oral Precancerous Lesions. Nutrition in Clinical Care 2001; 4: 94-102. Mehta FS, Shroff BC, Gupta PC , Daftary DK. Oral leukoplakia in relation to tobacco habits. A ten-year follow-up study of Bombay policemen. Oral Surg Oral Med Oral Pathol 1972; 34: 426-33. Merletti F, Boffetta P, Ciccone G, Mashberg A , Terracini B. Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy. Cancer Res 1989; 49: 4919-24. Miller CS , Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.[see comment]. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics 2001; 91: 622-35. Miller CS , White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma - A retrospective review of the literature. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 1996; 82: 57-68. Moberg M, Gustavsson I , Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003; 41: 3221-8. Molden T, Kraus I, Karlsen F, Skomedal H, Nygard JF , Hagmar B. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 2005; 14: 367-72. Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, Haroun F, Sednaoui P, Monfort L, Dachez R , Syrjanen K. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol 2005; 99: 160-8. Munger K, Phelps WC, Bubb V, Howley PM , Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989; 63: 4417-21. Nagao T, Ikeda N, Fukano H, Hashimoto S, Shimozato K , Warnakulasuriya S. Incidence rates for oral leukoplakia and lichen planus in a Japanese population. J Oral Pathol Med 2005; 34: 532-9. Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ , Toner PG. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis 2003; 9: 129-37. Nielsen H, Norrild B, Vedtofte P, Praetorius F, Reibel J , Holmstrup P. Human papillomavirus in oral premalignant lesions. Eur J Cancer 1996; Part B, Oral Oncology. 32B: 264-70. Niv A, Sion-Vardi N, Gatot A, Nash M , Fliss DM. Identification and typing of human papillomavirus (HPV) in squamous cell carcinoma of the oral cavity and oropharynx. J Laryngol Otol 2000; 114: 41-6. Oda H, Kumar S , Howley PM. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc Natl Acad Sci U S A 1999; 96: 9557-62. Pagano M, Durst M, Joswig S, Draetta G , Jansen-Durr P. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene 1992; 7: 1681-6. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994; 8: 283-95. Palefsky JM , Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4: 415-28. Palefsky JM, Silverman S, Jr., Abdel-Salaam M, Daniels TE , Greenspan JS. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 1995; 24: 193-7. Pillai MR, Phanidhara A, Kesari AL, Nair P , Nair MK. Cellular manifestations of human papillomavirus infection in the oral mucosa. J Surg Oncol 1999; 71: 10-5. Pindborg JJ, Jolst O, Renstrup G , Roed-Petersen B. Studies in oral leukoplakia: a preliminary report on the period pervalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. J Am Dent Assoc 1968; 76: 767-71. Premoli-De-Percoco G, Ramirez JL , Galindo I. Correlation between HPV types associated with oral squamous cell carcinoma and cervicovaginal cytology: An in situ hybridization study. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics 1998; 86: 77-81. Puthenveettil JA, Frederickson SM , Reznikoff CA. Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells. Oncogene 1996; 13: 1123-31. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV , Layfield LJ. Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV. Diagn Cytopathol 2003; 29: 149-55. Reichart PA , Philipsen HP. Oral erythroplakia--a review. Oral Oncol 2005; 41: 551-61. Remmerbach TW, Brinckmann UG, Hemprich A , Liebert UG. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 2004; 30: 302-8. Roed-Petersen B. Effect on oral leukoplakia of reducing or ceasing tobacco smoking. Acta Derm Venereol 1982; 62: 164-7. Romano JW, Williams KG, Shurtliff RN, Ginocchio C , Kaplan M. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol Invest 1997; 26: 15-28. Rothman KJ. Tobacco habits. Am J Public Health 1986; 76: 133. Scheffner M, Huibregtse JM, Vierstra RD , Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-505. Scheffner M, Werness BA, Huibregtse JM, Levine AJ , Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36. Scheifele C , Reichart PA. Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 2003; 39: 470-5. Schmitt M, Bravo IG, Snijders PJF, Gissmann L, Pawlita M , Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006; 44: 504-512. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A , zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111-4. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT , Zheng JW. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 2006; 35: 653-657. Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 1999; 42: 206-20. Sexton CJ, Proby CM, Banks L, Stables JN, Powell K, Navsaria H , Leigh IM. Characterization of factors involved in human papillomavirus type 16-mediated immortalization of oral keratinocytes. J Gen Virol 1993; 74: 755-61. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H , de Villiers EM. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994; 54: 4610-3. Shear M , Pindborg JJ. Verrucous hyperplasia of the oral mucosa Cancer 1980; 46: 1855-62. Shiu MN. The Natural History of Leukoplakia and Oral cancer. Master Thesis, National Taiwan University, 1997. Shroyer KR , Greer RO, Jr. Detection of human papillomavirus DNA by in situ DNA hybridization and polymerase chain reaction in premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol 1991; 71: 708-13. Silverman S, Bhargava K, Smith LW , Malaowalla AM. Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer 1976; 38: 1790-5. Silverman S, Jr., Gorsky M, Lozada-Nur F , Liu A. Oral mucous membrane pemphigoid. A study of sixty-five patients. Oral Surg Oral Med Oral Pathol 1986; 61: 233-7. Silverman S, Jr., Gorsky M , Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53: 563-8. Smits HL, van Gemen B, Schukkink R, van der Velden J, Tjong AHSP, Jebbink MF, ter Schegget J , Tjong-A-Hung SP. Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. J Virol Methods 1995; 54: 75-81. Snijders PJ, van den Brule AJ, Meijer CJ, Snijders PJF, van den Brule AJC , Meijer CJLM. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 2003; 201: 1-6. Sonnex C. Human papillomavirus infection with particular reference to genital disease. J Clin Pathol 1998; 51: 643-8. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R , Bultmann B. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 2004; 74: 107-16. Stoler MH, Schiffman M , Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study G. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.[see comment]. JAMA 2001; 285: 1500-5. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S , Burk RD. Human papillomavirus type 16 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37581 | - |
| dc.description.abstract | 背景:
口腔頰黏膜鱗狀細胞癌是台灣最常見的口腔惡性腫瘤，其中嚼檳榔是頰黏膜癌最重要的致癌危險因子。然而先前的研究發現人類乳突瘤病毒感染，特別是高危險型人類乳突瘤病毒感染，可能在口腔鱗狀細胞癌，尤其是和口腔習慣不相關的口腔鱗狀細胞癌，致癌機轉中扮演重要的角色。 方法: 為了探討人類乳突瘤病毒在口腔頰黏膜癌致癌機轉上所扮演的角色，本實驗利用來自100個頰黏膜癌前病變標本，包括30 個上皮增生、25個疣狀增生、15個輕度上皮變異、16個中度上皮變異、14個重度上皮變異以及30個正常口腔黏膜(NOM)標本純化出的去氧核糖核酸 (DNA)，利用巢式聚合酶鏈反應 (nested-PCR)、直接基因定序法，同時配合人類乳突瘤病毒基因晶片，來作人類乳突瘤病毒定型 (typing) 的工作，以此方法可在一次反應中偵測出39種不同人類乳突瘤病毒的基因型。研究不同口腔癌前病變疾病標本的人類乳突瘤病毒盛行率之外，本實驗也探討人類乳突瘤病毒感染與臨床病理參數間的關係，並以卡方檢定作統計分析。 結果: 本實驗發現，人類乳突瘤病毒在頰黏膜癌前病變標本的感染率 (21%) 與在正常口腔黏膜標本的感染率(20%)，並無統計學上有意義的差異；如將頰黏膜癌前病變患者，分為有口腔習慣者與無口腔習慣者兩組後，無口腔習慣頰黏膜癌前病變的人類乳突病毒感染率 (30%, 8/27)，高於有口腔習慣的頰黏膜癌前病變的人類乳突病毒感染率 (18%, 13/73)，但此差異亦無統計學上的意義。人類乳突瘤病毒的陽性感染率與癌前病變組織型態 (P = 0.012) 及疾病進展 (P = 0.078) 有顯著相關，其中人類乳突瘤病毒感染較常出現於疣狀增生與重度上皮變異癌前病變。人類乳突瘤病毒陽性癌前病變的惡性轉變率 (62%, 13/21) 高於人類乳突瘤病毒陰性癌前病變的惡性轉變率 (39%, 31/79 )，其中高危險型人類乳突瘤病毒陽性癌前病變與多種人類乳突瘤病毒陽性癌前病變，具有較高的惡性轉變率，分別為 77.8% (7/9) 與 100% (3/3)，低危險型人類乳突瘤病毒陽性癌前病變的惡性轉變率則為 33% (3/9)。高危險型與多種人類乳突瘤病毒陽性的癌前病變，具有較高機會惡化或惡性轉變 (P = 0.044)。 結論: 本實驗結果認為高危險型與多種的人類乳突瘤病毒感染，在頰黏膜癌前病變的惡性轉變過程中，扮演重要的角色，尤其是在口腔習慣不相關的頰黏膜癌前病變的惡性轉變過程中，扮演重要的角色。 | zh_TW |
| dc.description.abstract | Background
Buccal squamous cell carcinoma (SCC) is the most common oral malignant tumor in Taiwan. Betel quid (BQ) chewing is the most important risk factor for the buccal mucosal carcinogenesis. Previous studies showed that human papillomaviruses (HPVs), particularly high-risk HPVs, play an important role in the development of oral SCCs (OSCCs), especially the non-oral habits (OH)-associated OSCCs. Materials and methods To evaluate the etiologic role of HPVs in buccal mucosal carcinogenesis, DNA samples were purified from 100 buccal premalignant lesions, including 30 hyperkeratosis, 25 verrucous hyperplasia, 15 mild dysplasia, 16 moderate dysplasia, and 14 severe dysplasia lesions, and 30 normal oral mucosa (NOM) specimens. A nested-polymerase chain reaction, DNA sequencing, and gene-chip HPV typing was used to detect 39 subtypes of HPV DNA in our samples. The HPV prevalence rates in different buccal premalignant groups and their correlation with clinicopathological parameters of patients with buccal premalignant lesions were analyzed by chi-square test. Results There was no significant difference in the overall HPV-positive rate between buccal premalignant lesion samples (21%) and NOM samples (20%). The overall HPV-positive rate was higher in non-OH-associated premalignant lesion samples (30%, 8/27) than in OH-associated premalignant lesion samples (18%, 13/73), although the difference was not significant. The HPV positivity was significantly associated with histological type of disease (P = 0.012) and disease progression (P = 0.078, marginal significance). HPV infection occurred more frequently in oral verrucous hyperplasia and severe dysplasia lesions than in other premalignant lesions. Moreover, the malignant transformation rate was higher in HPV-positive premalignant lesions (62%, 13/21) than in HPV-negative premalignant lesions (39%, 31/79). The malignant transformation rate was 78% (7/9) for premalignant lesions with high-risk HPV infection, 33% (3/9) for those with low-risk HPV infection, and 100% (3/3) for those with multiple HPV infections. Premalignant lesions with high-risk or multiple HPV infections had greater potential to become a more advanced premalignant lesion or a malignancy (P = 0.044). Conclusions High-risk and multiple HPV infections may play an important role in the transformation of a buccal premalignant lesion, especially a non-OH-associated buccal premalignant lesion, into an oral SCC. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T15:33:37Z (GMT). No. of bitstreams: 1 ntu-97-P94422002-1.pdf: 783873 bytes, checksum: b002079cac6aa87937f0c15d2d7d4366 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 口試委員會審定書..................................................................................... 2
誌謝............................................................................................................. 3 中文摘要..................................................................................................... 6 英文摘要..................................................................................................... 8 Background................................................................................................. 10 Purposes of this study................................................................................... 11 Literature Review Part 1: Introduction of oral premalignant lesions.................................... 12 I. Epidemiology.................................................................................. 13 II. Classification and clinical presentation................................................ 15 III. Risk factors..................................................................................... 20 IV. Malignant transformation.................................................................. 23 Part 2: Introduction of Human Papilloma viruses................................... 27 I. General view of HPV........................................................................ 27 II. Pathogenesis of human papilloma viruses............................................. 31 III. The relationship of oral premalignant lesions to HPV............................. 34 Part 3: Methods for detection and typing of HPVs................................. 37 I. Methods for HPV detection............................................................... 37 II. Methods for HPV genotyping............................................................ 38 Materials and methods Part 1: Patients and specimens................................................................ 47 Part 2: DNA extraction........................................................................... 48 Part 3: HPV detection by nested-PCR.................................................... 48 Part 4: HPV genotyping by microarray genechip................................... 49 Part 5: HPV genotyping by DNA sequencing analysis............................. 51 Part 6: Statistical analysis....................................................................... 51 Result Part 1: DNA extraction............................................................................ 52 Part 2: HPV genotyping.......................................................................... 52 Part 3: Correlation between HPV positivity and clinicopathological parameters.................................................................................... 53 Part 4: Correlation between HPV positivity and clinicopathological parameters in OH-associated or non-OH associated premalignant lesion groups................................................................................ 53 Part 5: Disease progression and malignant transformation rates in buccal premalignant lesions.................................................................... 54 Part 6: Correlation of high-risk, low-risk and multiple HPV infections with disease progression...................................................................... 54 Discussion........................................................................................... 56 Conclusions........................................................................................ 61 References.......................................................................................... 63 Tables.................................................................................................. 81 Figures................................................................................................ 88 | |
| dc.language.iso | en | |
| dc.subject | 人類乳頭瘤病毒 | zh_TW |
| dc.subject | 口腔頰黏膜癌前病變 | zh_TW |
| dc.subject | premalignant lesions | en |
| dc.subject | human papillomavirus | en |
| dc.title | 人類乳頭瘤病毒與口腔頰黏膜癌前病變的關係 | zh_TW |
| dc.title | Association of human papillomavirus with oral buccal mucosa premalignant lesions | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 關學婉,張龍昌 | |
| dc.subject.keyword | 口腔頰黏膜癌前病變,人類乳頭瘤病毒, | zh_TW |
| dc.subject.keyword | human papillomavirus,premalignant lesions, | en |
| dc.relation.page | 89 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-14 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
| 顯示於系所單位： | 臨床牙醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 765.5 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。